Issues affecting the longevity of the continuous peritoneal dialysis therapy

Y. Kawaguchi, T. Hasegawa, Masaaki Nakayama, H. Kubo, T. Shigematu

研究成果: Article査読

94 被引用数 (Scopus)


Continuous ambulatory peritoneal dialysis (CAPD) is one of the accepted dialysis modalities worldwide. However, the longevity of the CAPD technique and the patient survival associated with this modality have not been established. We review our 16 year experience in one treatment center in 224 patients who underwent CAPD. Overall, these patients survived on CAPD for a mean of 6.6 years; a 50% survival was reached at a mean of 5.5 years. Ultrafiltration loss was the most prominent cause of withdrawal from CAPD among patients in whom the technique was successful for more than 6 years. Countermeasures to decrease the CAPD-associated morbidity are crucial to prolonging the success of the technique, and thus increasing the duration of patient survival.

ジャーナルKidney International, Supplement
出版ステータスPublished - 1997 1月 1

ASJC Scopus subject areas

  • 腎臓病学


「Issues affecting the longevity of the continuous peritoneal dialysis therapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。